Skip to content

Clinical trials

Mesothelioma, Malignant trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma, Malignant Country / region: United Kingdom Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20032
20052
20061
20071
20101
20111
20121
20132
20141
20153
20172
20182
20194
20202
20211
20224
20234
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Terminated7
Recruiting5
Unknown status4
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC5
Papworth Hospital NHS Foundation Trust2
University College, London2
Verastem, Inc.2
AGC Biologics S.p.A.1
AstraZeneca1
Barts & The London NHS Trust1
Bayer1
BerGenBio ASA1
British Thoracic Society1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma, Malignant38
Carcinoma, Non-Small-Cell Lung6
Mesothelioma6
Neoplasms4
Melanoma3
Neoplasm Metastasis3
Pleural Effusion, Malignant3
Stomach Neoplasms3
Carcinoma, Transitional Cell2
Colorectal Neoplasms2

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.